IIT RESEARCH INSTITUTE

LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL.

MODIFICATION TO DE-OBLIGATE EXPIRING FY19 FUNDS

PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES

TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS"

TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531

PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION

IITRI - PERFORMANCE AREA 1 TO2 PERFORMANCE AREA I-MANAGEMENT AND OPERATIONS SUPPORT

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

IITRI - PTTP DRF BPN STUDY - TO3

BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013

FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102

IITRI -DOG MTD-DRF STUDIES-TO 4

TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION

TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2

NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION.

EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER

IITRI - PTTP DRF BPN STUDY - TO3

PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531

NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION.

NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2021. MOD P00005 FOR NO-COST EXTENSION.

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

IITRI -DOG MTD-DRF STUDIES-TO 4

PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 08/15/2020.

IITRI - PTTP DRF BPN STUDY - TO3

IITRI - PERFORMANCE AREA 1 TO2

NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION.

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL.

LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL.

DEOBLIGATION OF SUBCLINS: CLIN 000103, ACRN AA IN THE AMOUNT OF $37,106.05 AND CLIN 000202, ACRN AA IN THE AMOUNT OF $2,967.08.

BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013

TO CORRECT AN ADMINISTRATIVE FUNDING ERROR. FUNDS WERE NOT OBLIGATED CORRECTLY ON THE BASE TASK ORDER F AWARD. THIS MODIFICATION CORRECTLY ADDS FUNDING AND ISSUES TASK ORDER HHSN27200001, TASK AREA F, BASE IDIQ CONTRACT KICK-OFF

NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO)

PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

SINGLE PO DOSE CARDIOVASCULAR AND PULMONARY SAFETY PHARMACOLOGY STUDY OF METARRESTIN IN TELEMETERED BEAGLE DOGS USING LATIN-SQUARE CROSS OVER STUDY

NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION.

NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION

NON-CLINICAL SAFETY ASSESSMENT OF BPN14770 TO SUPPORT PEDIATRIC POPULATION WITH FRAGILE X SYNDROME. MOD TO TRANSFER GOVERNMENT PROPERTY FROM THIS TASK ORDER TO TASK ORDER NUMBER 75N95020F00001 UNDER IDIQ CONTRACT NUMBER HHSN271201700016I.

IIT RESEARCH INSTITUTE:1107221 [18-004523] - TASK ORDER TITLE: "28 DAY IV TOXICITY STUDY OF AXER-204 IN RATS"

IIT RESEARCH INSTITUTE:1107221 - TASK ORDER 04 "SPIF 3 MONTHS SUBCUTANEOUS TOXICITY STUDIES IN DOGS AND MICE."

IGFOTIGF, IN VIVO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS

TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION